Skip to main content

Dan Crenshaw on Modernizing the FDA for Science and Consumer Needs

Forbes Breaking NewsAugust 7, 20254 min1,279 views
17 connections·21 entities in this video→

Modernizing FDA Systems

  • 🎯 Dan Crenshaw highlights that some FDA systems have not kept pace with modern science and consumer needs.
  • πŸ’‘ He supports the bipartisan reauthorization of the over-the-counter monograph user fee program, which includes smart updates.
  • βœ… This program aims to keep everyday medicines like allergy meds, cold remedies, and sunscreen safe and up-to-date without adding red tape.

Transparency and Flexibility

  • πŸ”‘ The reauthorization brings more transparency, scientific flexibility, and accountability to the system.
  • πŸ“ˆ Over 90% of Americans rely on OTC products to manage their health, avoid unnecessary doctor visits, benefiting families, rural communities, and the workforce.
  • πŸ”¬ The legislation formally allows the use of voluntary consensus standards and alternative testing methods for monograph updates.

Scientific Flexibility and Efficiency

  • πŸ§ͺ Dr. Corgan Karee explains that voluntary consensus standards are known, transparent, and reliable.
  • βš™οΈ Alternative testing methods, including alternatives to animal testing, will be used across the board for both OTC and prescription drugs if they can answer safety questions.
  • πŸš€ The FDA is working to update outdated tests and incorporate the most up-to-date testing methods to get accurate answers.

FDA's Role in Innovation and Safety

  • πŸ‡ΊπŸ‡Έ Crenshaw emphasizes maintaining safety standards while making the FDA an efficient process that does not destroy the innovative industry in the United States.
  • ⚠️ The FDA is overseeing and looking at safety and effectiveness, including updates for acetaminophen safety, phenylphrine efficacy, pediatric dosing, and NSAIDs for pregnant women.
  • πŸ₯ In rural communities, reliable over-the-counter medications are essential due to limited access to physicians.
Knowledge graph21 entities Β· 17 connections

How they connect

An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.

Hover Β· drag to explore
21 entities
Chapters3 moments

Key Moments

Transcript18 segments

Full Transcript

Topics14 themes

What’s Discussed

FDAOver-the-Counter (OTC) MonographUser Fee ProgramModern ScienceConsumer NeedsBipartisan LegislationTransparencyScientific FlexibilityAccountabilityVoluntary Consensus StandardsAlternative Testing MethodsRural HealthDrug SafetyDrug Efficacy
Smart Objects21 Β· 17 links
CompanyΒ· 1
MediasΒ· 2
ConceptsΒ· 6
ProductsΒ· 11
PersonΒ· 1